CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,662 | -24.8% | 1,488 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $87,280 | +8.4% | 1,498 | -12.8% | 0.00% | 0.0% |
| Q1 2023 | $80,529 | +5.4% | 1,718 | -4.5% | 0.00% | 0.0% |
| Q4 2022 | $76,414 | -40.1% | 1,799 | -5.4% | 0.00% | 0.0% |
| Q3 2022 | $127,637 | -53.3% | 1,901 | -55.2% | 0.00% | -66.7% |
| Q2 2022 | $273,286 | -1.3% | 4,245 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $276,996 | +140.2% | 4,150 | +169.5% | 0.00% | +200.0% |
| Q4 2021 | $115,332 | – | 1,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |